Full List Of Stories
AstraZeneca COPD drug wins EU marketing approval
AstraZeneca said its Trixeo Aerosphere had been given marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Europe midday: Shares start to give up early gains
European shares were giving up early gains by midday as the impetus provided by upbeat earnings reports and strong China GDP data started to wane.
Europe open: Shares up as upbeat earnings overshadow Covid worries
European shares opened the week higher on upbeat earnings reports and strong China GDP data as investors set aside worries over increasing coronavirus infections and renewed lockdowns.
Flybe eyes 2021 restart after sale to Cyrus Capital affiliate
Regional airline Flybe could be back in the air next year as administrators announced a deal with an affiliate of a firm involved in its last financial rescue.
G4S again rejects Gardaworld £3bn bid
Security firm G4S on Monday again rejected GardaWorld’s £3bn offer as the Canadian company posted full details of its 190p-a-share bid.